Canada Artificial Intelligence In Cancer Diagnostics Market Size & Outlook
Related Markets
Canada artificial intelligence in cancer diagnostics market highlights
- The Canada artificial intelligence in cancer diagnostics market generated a revenue of USD 9.6 million in 2023 and is expected to reach USD 49.2 million by 2030.
- The Canada market is expected to grow at a CAGR of 26.2% from 2024 to 2030.
- In terms of segment, software was the largest revenue generating component type in 2023.
- Software is the most lucrative component type segment registering the fastest growth during the forecast period.
Artificial intelligence in cancer diagnostics market data book summary
| Market revenue in 2023 | USD 9.6 million |
| Market revenue in 2030 | USD 49.2 million |
| Growth rate | 26.2% (CAGR from 2023 to 2030) |
| Largest segment | Software |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Hardware, Services |
| Key market players worldwide | Microsoft Corp, Roche Holding AG, Quest Diagnostics Inc, Medial EarlySign, CancerCenter.AI, Therapixel, Tempus, Kheiron, SkinVision |
Other key industry trends
- In terms of revenue, Canada accounted for 5.0% of the global artificial intelligence in cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. artificial intelligence in cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 49.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence In Cancer Diagnostics Market Scope
Artificial Intelligence In Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SkinVision | View profile | 11-50 | Amsterdam, Noord-Holland, The Netherlands, Europe | https://skinvision.com |
| Kheiron | View profile | 11-50 | London, England, United Kingdom, Europe | https://www.kheironmed.com/ |
| Tempus | View profile | 501-1000 | Chicago, Illinois, United States, North America | https://www.tempus.com |
| Therapixel | View profile | 11-50 | Nice, Provence-Alpes-Cote d'Azur, France, Europe | http://www.therapixel.com/ |
| CancerCenter.AI | View profile | 11-50 | Wroclaw, Dolnoslaskie, Poland, Europe | https://cancercenter.ai |
| Medial EarlySign | View profile | 11-50 | Hod Hasharon, HaMerkaz, Israel, Asia | http://earlysign.com/ |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Microsoft Corp | View profile | 221000 | One Microsoft Way, Redmond, WA, United States, 98052-6399 | https://www.microsoft.com |
Canada artificial intelligence in cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in cancer diagnostics market will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 43.75% in 2024. Horizon Databook has segmented the Canada artificial intelligence in cancer diagnostics market based on software, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
The increase in adoption of AI in cancer diagnostics has contributed to market growth in Canada. For instance, Toronto’s Humber River Hospital (HRH), in collaboration with GE Healthcare, installed a medical imaging tile that is a combination of artificial and human intelligence to analyze real-time data. The HRH’s imaging tile was developed with the help of machine learning technology, which operates at a 95% accuracy rate.
According to TriMed Media Group, Inc., in 2018, HRH experienced an 8% increase in daily visits since the hospital installed its medical imaging tile. Postinstallation, the hospital noticed an improvement in inpatient exam turnaround times for ultrasounds by 14%, MRIs by 10%, and CT scans by 8%.
Growing investments in AI for cancer diagnostics by the Canadian government are also fueling growth of the market in Canada. According to Canadian Healthcare Technology, in June 2018, the Canadian government invested USD 24.9 billion to launch a research program in the field of AI and healthcare.
Reasons to subscribe to Canada artificial intelligence in cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada artificial intelligence in cancer diagnostics market databook
-
Our clientele includes a mix of artificial intelligence in cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada artificial intelligence in cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada artificial intelligence in cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada artificial intelligence in cancer diagnostics market size, by component type, 2018-2030 (US$M)
Canada Artificial Intelligence In Cancer Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
